by Medicine by Design | Apr 22, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of proflies that feature “people” of Medicine by Design. Some minor edits...
by Laine Bodnar | Feb 29, 2024
In my role as a communication professional at CCRM, I have had the opportunity to attend industry conferences and events. There, I have met brilliant minds in the regenerative medicine and cell therapy field and learned about the work that’s happening in their...
by Stacey Johnson | Feb 23, 2024
As a fair-skinned, freckled person (my mom says she painted them on me while I slept), and one who has a family history of skin cancers and melanoma, the news on February 19 that Iovance Biotherapeutics’ AMTAGVITM received U.S. Food and Drug Administration (FDA)...
by Krystal Jacques | Jan 10, 2024
The Second World War (WWII) and post WWII saw an appetite for new technology and science. In particular, after WWII scientists were encouraged to conduct research for the sake of knowledge and to benefit society. However, there weren’t as many opportunities outside of...
by CCRM Australia | Sep 28, 2023
This blog post was written by Jimmy Yu (see LinkedIn page) with supervision by Dr. Chih Wei Teng. Countries that responded better during the COVID-19 pandemic showed good, coordinated efforts between different government agencies and departments. Known as the...
by Stacey Johnson | Sep 8, 2023
In 2019, CCRM launched a new blog to explain products, processes, terms, technologies, techniques and much more related to developing and manufacturing cell and gene therapy products. As a contract development and manufacturing organization (CDMO), CCRM wanted to...
Comments